• Opinion
• [Reporter’s View] MSD Korea ‘Calm before the storm’
• by Jung, Sae-Im May 11, 2023 05:46am

• Company
• Scemblix can be prescribed at general hospitals
• by Eo, Yun-Ho May 10, 2023 11:18pm

• Company
• Negotiation on the price of Onureg has started
• by Eo, Yun-Ho May 10, 2023 11:17pm

• Policy
• A benefit study of the Gardasil 9 NIP is also forthcoming
• by Lee, Jeong-Hwan May 10, 2023 11:17pm

• Policy
• Prior HIRA approval is required to administer Crysvita
• by Lee, Tak-Sun May 10, 2023 06:00am

• Company
• Forxiga, has the largest number of clinical trials
• by Jung, Sae-Im May 10, 2023 05:58am

• Company
• Betmiga generics’ market share rises to 49%...
• by Kim, Jin-Gu May 9, 2023 05:38am

• Policy
• Insurance price ceiling reeval results to be notified soon
• by Lee, Tak-Sun May 9, 2023 05:38am

• Company
• Ildong’s diabetes combi Qtern registered for reimbursement
• by Kim, Jin-Gu May 8, 2023 05:41am

• Policy
• Retevmo passes DREC review and undergoes negotiations
• by Lee, Tak-Sun May 8, 2023 05:41am